962 resultados para Philodemus, approximately 110 B.C.-approximately 40 B.C.


Relevância:

60.00% 60.00%

Publicador:

Resumo:

O objetivo deste trabalho foi avaliar a influência do pH e da adição de carbonatos, fosfatos e sulfatos na movimentação do nitrato, em colunas constituídas do horizonte subsuperficial de um Latossolo Vermelho Acriférrico. Os experimentos foram realizados de acordo com a técnica do deslocamento miscível. Utilizaram-se como pulso de nitrato soluções de KNO3 a 10 ou 40 mmol L-1. Em cada coluna, foram obtidas curvas de transposição do elemento. A carga líquida do solo nos diferentes tratamentos variou de - 24,0 a +35,0 mmol c L-1. Nos tratamentos que receberam adição de ácido clorídrico, ácido clorídrico + fosfato, carbonato + fosfato e sulfato, as recuperações de nitrato foram maiores do que o total aplicado no pulso. As adições de carbonatos, fosfato e sulfato favoreceram a lixiviação de nitrato, e deslocaram as curvas de transposição para a esquerda. A acidificação do solo retardou o deslocamento do nitrato, e deslocaram as curvas de transposição para a direita. A movimentação de nitrato no solo foi mais influenciada pelo pH do meio, pela presença de carbonatos, fosfatos e sulfatos, do que pela força iônica do pulso.

Relevância:

60.00% 60.00%

Publicador:

Resumo:

BACKGROUND: Chronic liver disease in human immunodeficiency virus (HIV)-infected patients is mostly caused by hepatitis virus co-infection. Other reasons for chronic alanine aminotransferase (ALT) elevation are more difficult to diagnose. METHODS: We studied the incidence of and risk factors for chronic elevation of ALT levels (greater than the upper limit of normal at 2 consecutive semi-annual visits) in participants of the Swiss HIV Cohort Study without hepatitis B virus (HBV) or hepatitis C virus (HCV) infection who were seen during the period 2002-2008. Poisson regression analysis was used. RESULTS: A total of 2365 participants were followed up for 9972 person-years (median age, 38 years; male sex, 66%; median CD4+ cell count, 426/microL; receipt of antiretroviral therapy [ART], 56%). A total of 385 participants (16%) developed chronic elevated ALT levels, with an incidence of 3.9 cases per 100 person-years (95% confidence interval [CI], 3.5-4.3 cases per 100 person-years). In multivariable analysis, chronic elevated ALT levels were associated with HIV RNA level >100,000 copies/mL (incidence rate ratio [IRR], 2.23; 95% CI, 1.45-3.43), increased body mass index (BMI, defined as weight in kilograms divided by the square of height in meters) (BMI of 25-29.9 was associated with an IRR of 1.56 [95% CI, 1.24-1.96]; a BMI 30 was associated with an IRR of 1.70 [95% CI, 1.16-2.51]), severe alcohol use (1.83 [1.19-2.80]), exposure to stavudine (IRR per year exposure, 1.12 [95% CI, 1.07-1.17]) and zidovudine (IRR per years of exposure, 1.04 [95% CI, 1.00-1.08]). Associations with cumulative exposure to combination ART, nucleoside reverse-transcriptase inhibitors, and unboosted protease inhibitors did not remain statistically significant after adjustment for exposure to stavudine. Black ethnicity was inversely correlated (IRR, 0.52 [95% CI, 0.33-0.82]). Treatment outcome and mortality did not differ between groups with and groups without elevated ALT levels. CONCLUSIONS: Among patients without hepatitis virus co-infection, the incidence of chronic elevated ALT levels was 3.9 cases per 100 person-years, which was associated with high HIV RNA levels, increased BMI, severe alcohol use, and prolonged stavudine and zidovudine exposure. Long-term follow-up is needed to assess whether chronic elevation of ALT levels will result in increased morbidity or mortality.